Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update-Reference-Cited by-同舟云学术

Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update

Published:2022-11-09 Issue:11 Volume:34 Page:2591-2602
ISSN:1720-8319
Container-title:Aging Clinical and Experimental Research
language:en
Short-container-title:Aging Clin Exp Res

Author:

Messina Osvaldo Daniel,Vidal Maritza^ORCID,Torres Jorge A Morales,Vidal Luis Fernando,Arguissain Constanza,Pereira Rosa María,Clark Patricia,Cerdas Perez Sonia,Campusano Claudia,Lazaretti-Castro Marise,Zerbini Cristiano,Scali Juan J.,Mendez Sanchez Lucia,Peralta-Pedrero Maria L.,Cavallo Andrea,Valdivia Ibarra Francisco J.,Hernandez Pérez Talina

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Aging

Link

https://link.springer.com/content/pdf/10.1007/s40520-022-02261-2.pdf

Reference86 articles.

1. Walsh LJ, Wong CA, Pringle M et al (1996) Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313:344–346

2. Van Staa TP, Leufkens HG, Abenhaim L et al (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

3. Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787

4. Van Staa TP, Laan RF, Barton IP et al (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224–3229

5. Kaji H, Yamauchi M, Chihara K et al (2006) The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis. Endocr J 53:27–34

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis;PAIN, JOINTS, SPINE;2024-09-08

2. Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study;Osteoporosis International;2024-07-02

3. A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease;Steroids;2024-07

4. Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases;Nature Reviews Rheumatology;2024-06-03

5. Fufang Zhenshu Tiaozhi capsule enhances bone formation and safeguards against glucocorticoid-induced osteoporosis through innovative Mekk2-mediated β-catenin deubiquitination;Journal of Bone and Mineral Metabolism;2024-05-16